Friday, 29 March 2024


Erba launches advanced SARS-CoV-2 RT-PCR assay with RT storage

22 January 2021 | News

To overcome challenges in existing COVID-19 molecular tests assays by improved detection, easy single-tube multiplex master mix, and compatible storage

Photo Credit: ERBA

Photo Credit: ERBA

In response to the ongoing COVID-19 pandemic, on Jan 21, 2021 Erba launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2.

To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge(UK)-based development team has carefully engineered a new assay to improve detection and ease of use with a single tube multiplex mastermix, compatible with room-temperature storage and transportation.

The new assay offers 200 copies/ml LoD, using universally trusted gene targets highly specific for SARS-CoV-2 and updated primer sequences to maximise long term performance. Sample types include both nasopharyngeal and oropharyngeal swabs as well as saliva.

Nikhil Vazirani, MD of Erba, said: "We are proud and excited to add a highly sensitive RT-PCR test to our growing range of immunoassay and molecular solutions. The new ErbaMDx SARS-CoV-2 test perfectly complements our successful COVID-19 IgG and IgM ELISA assays to offer customers a state-of-the-art molecular test in addition to antibody testing which will offer clinicians valuable insight into the immune response to infection or vaccination."

The CE-marked kit will be available through Erba's global distribution network.

Erba was founded in 1979 as Transasia Bio-Medicals Ltd. by Suresh Vazirani who recognized the need for dedicated healthcare solutions for developing nations after witnessing the short comings of the healthcare systems in his home country India. 

 

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account